Company / Gross Profit per Share
Dexcom Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$7.28
FY2025
5-year range
$3.30 / $17.49
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
#60 of 99
Health Care
What the data says
At $7.28, Dexcom's gross profit per share ranks #60 of 99 in the Health Care sector. Gross Profit per Share has increased for 3 consecutive years, from $3.30 in FY2022 to $7.28 in FY2025.
Based on SEC 10-K filings.
7.28 in FY2025 with a 5-year CAGR of -11.4%.
Improved from $5.94 to $7.28 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +30.2%
- 5-Year CAGR
- -11.4%
- 10-Year CAGR
- -
Sector benchmark
#60 of 99 in Health CareTop 61% of 99This company $7.28 Sector average $13.82
▼
-47.3% below sector average
Key checks
Key Insights
- Dexcom's gross profit per share has grown for 3 consecutive years.
- In FY2025, gross profit per share increased 16.7% year-over-year.
- Ranks #60 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.28 | +16.7% |
| FY2024 | $6.24 | +5.1% |
| FY2023 | $5.94 | +80.0% |
| FY2022 | $3.30 | -81.1% |
| FY2021 | $17.49 | +31.3% |
| FY2020 | $13.32 | +31.0% |
| FY2019 | $10.17 | +33.3% |
| FY2018 | $7.63 | +131.9% |
| FY2017 | $3.29 | +52.5% |
| FY2016 | $2.16 | +66.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026